Temporal molecular and biological assessment of an erlotinib-resistant lung adenocarcinoma model reveals markers of tumor progression and treatment response

  1. Weaver, Z.
  2. Difilippantonio, S.
  3. Carretero, J.
  4. Martin, P.L.
  5. El Meskini, R.
  6. Iacovelli, A.J.
  7. Gumprecht, M.
  8. Kulaga, A.
  9. Guerin, T.
  10. Schlomer, J.
  11. Baran, M.
  12. Kozlov, S.
  13. McCann, T.
  14. Mena, S.
  15. Al-Shahrour, F.
  16. Alexander, D.
  17. Wong, K.-K.
  18. Van Dyke, T.
Aldizkaria:
Cancer Research

ISSN: 0008-5472,  1538-7445

Argitalpen urtea: 2012

Alea: 72

Zenbakia: 22

Orrialdeak: 5921-5933

Mota: Artikulua

DOI: 10.1158/0008-5472.CAN-12-0736 GOOGLE SCHOLAR lock_openSarbide irekia editor

Garapen Iraunkorreko Helburuak

Datuen iturria: Scopus